VERACYTE, INC. Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements
VERACYTE, INC. (VCYT) reported Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements of 2.09 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Notes
us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements · last filed 2026-07-31
- VERACYTE, INC. incremental common shares attributable to dilutive effect of share-based payment arrangements for the quarter ending 2026-06-30 was 2.09M shares.
- VERACYTE, INC. incremental common shares attributable to dilutive effect of share-based payment arrangements for the quarter ending 2026-03-31 was 1.78M shares, a 12.38% decline year-over-year.
- VERACYTE, INC. incremental common shares attributable to dilutive effect of share-based payment arrangements for the quarter ending 2025-09-30 was 967.00K shares, a 33.36% decline year-over-year.
- VERACYTE, INC. incremental common shares attributable to dilutive effect of share-based payment arrangements for the quarter ending 2025-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- VERACYTE, INC. incremental common shares attributable to dilutive effect of share-based payment arrangements for fiscal 2025 was 1.99M shares, a 18.53% increase from fiscal 2024.
- VERACYTE, INC. incremental common shares attributable to dilutive effect of share-based payment arrangements for fiscal 2024 was 1.68M shares.
- VERACYTE, INC. incremental common shares attributable to dilutive effect of share-based payment arrangements for fiscal 2023 was 0.00 shares.
- VERACYTE, INC. incremental common shares attributable to dilutive effect of share-based payment arrangements for fiscal 2022 was 0.00 shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 3 month | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 6 month | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 9 month | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 12 month |
|---|---|---|---|---|
| 2026-06-30 | 2.09M shares 10-Q · filed 2026-07-31 | 2.00M shares 10-Q · filed 2026-07-31 | ||
| 2026-03-31 | 1.78M shares 10-Q · filed 2026-05-06 | |||
| 2025-12-31 | 1.99M shares 10-K · filed 2026-02-26 | |||
| 2025-09-30 | 967.00K shares 10-Q · filed 2025-11-05 | 1.56M shares 10-Q · filed 2025-11-05 | ||
| 2025-06-30 | 0.00 shares 10-Q · filed 2026-07-31 | 1.69M shares 10-Q · filed 2026-07-31 | ||
| 2025-03-31 | 2.03M shares 10-Q · filed 2026-05-06 | |||
| 2024-12-31 | 1.68M shares 10-K · filed 2026-02-26 | |||
| 2024-09-30 | 1.45M shares 10-Q · filed 2025-11-05 | 1.23M shares 10-Q · filed 2025-11-05 | ||
| 2024-06-30 | 625.00K shares 10-Q · filed 2025-08-07 | 951.00K shares 10-Q · filed 2025-08-07 | ||
| 2024-03-31 | 0.00 shares 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | 0.00 shares 10-K · filed 2026-02-26 | |||
| 2023-09-30 | 0.00 shares 10-Q · filed 2024-11-07 | 0.00 shares 10-Q · filed 2024-11-07 | ||
| 2023-06-30 | 0.00 shares 10-Q · filed 2024-08-07 | 0.00 shares 10-Q · filed 2024-08-07 | ||
| 2022-12-31 | 0.00 shares 10-K · filed 2025-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |